RGBP — Regen BioPharma Inc
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1589150 ·
Last close
$0.00
Market Cap
$167.5K
52W High
$0.04
52W Low
$0.00
ADV30
8,688,366
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 59,065 | — | 24,529 | -637,785 | 287,587 | 239 | 6,165,793 |
| Mar 2026 | 59,065 | — | -153,709 | 991,927 | 260,194 | 271 | 5,619,062 |
| Dec 2025 | 59,065 | — | -551,624 | -967,853 | 237,076 | 4,578 | 6,810,073 |
| Sep 2025 | 59,366 | — | -123,055 | -572,469 | 274,628 | 69,555 | 6,555,811 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-477,156
Investing CF
—
Financing CF
$475,665
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.02
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-21,667,546
Inventory
—
Receivables
$259,723
ST Investments
—
EBIT TTM
$-506,765
Pretax Income TTM
$-715,687
Interest Exp TTM
$208,922
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$236,560
EBITDA
—
Free Cash Flow
$106,888
Enterprise Value
$1,242,055
Total Cash
$239
Total Debt
$891,757
Shares Out
1,675,277,503
Trailing EPS
$-0.02
Book Value
$-0.01
ROE
—
ROA
-207.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 236,561 | -338,540 | -1,274,502 | 274,628 | 6,555,811 | -6,281,183 | -383,591 |
| Sep 2024 | 236,560 | -417,221 | -668,255 | 161,084 | 5,378,456 | -5,217,372 | -751,536 |
| Sep 2023 | 236,560 | -686,949 | 1,023,508 | 353,617 | 5,457,616 | -5,103,999 | -173,917 |
| Sep 2022 | 235,517 | -339,605 | 2,227,034 | 559,002 | 8,595,061 | -8,036,059 | -606,921 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PTPI | Petros Pharmaceuticals, Inc. | $169.5K | $0.00 | — |
| CNBX | CNBX Pharmaceuticals Inc. | $160.6K | $0.00 | — |
| PRPH | ProPhase Labs, Inc. | $155.9K | $0.01 | — |
| OCEA | Ocean Biomedical, Inc. | $185.9K | $0.00 | — |
| AVCRF | Avricore Health Inc. | $101.1K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
2026-02-24 12:00 · Yahoo
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
2025-12-09 12:00 · Yahoo
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
2025-11-05 14:40 · Yahoo
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
2025-10-22 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.